Paper39665231
Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms.
Padalino G and 5 others. Microbiologyopen, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms. Papers, record 39665231. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39665231
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Quinoxalines | Major topic |
| Biofilms | Major topic |
| Enterococcus faecalis | Major topic |
| Microbial Sensitivity Tests | Major topic |
| Methicillin-Resistant Staphylococcus aureus | Major topic |
| Anti-Bacterial Agents | Major topic |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| This work was supported by Aberystwyth University (Technology Transfer Grant Development Award) and the Life Sciences Wales Research Network (a Welsh Government Ser Cymru initiative). | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37875605 | Quinoxalines against Leishmania amazonensis: SAR study, proposition of a new derivative, QSAR prediction, synthesis, and biological evaluation. | Sci Rep | 2023 | https://conductscience.org/library/papers/37875605 | PubMed |
| 2 | 29133557 | A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-Dependent Flavin Nitroreductase. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29133557 | PubMed |
| 3 | 37091673 | Understanding bacterial biofilms: From definition to treatment strategies. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37091673 | PubMed |
| 4 | 21553472 | [Study of antibiotic resistance of enterococci strains received in 2009 in the National Reference Centre for Enterococci]. | Bacteriol Virusol Parazitol Epidemiol | 2010 | https://conductscience.org/library/papers/21553472 | PubMed |
| 5 | 16621463 | Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America. | Int J Antimicrob Agents | 2006 | https://conductscience.org/library/papers/16621463 | PubMed |
| 6 | 27080241 | Distinguishing between resistance, tolerance and persistence to antibiotic treatment. | Nat Rev Microbiol | 2016 | https://conductscience.org/library/papers/27080241 | PubMed |
| 7 | 33732632 | Antibiotic resistance: Global health crisis and metagenomics. | Biotechnol Rep (Amst) | 2021 | https://conductscience.org/library/papers/33732632 | PubMed |
| 8 | 36339560 | Identification and metabolomic characterization of potent anti-MRSA phloroglucinol derivatives from Dryopteris crassirhizoma Nakai (Polypodiaceae). | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36339560 | PubMed |
| 9 | 25128670 | Present status of quinoxaline motifs: excellent pathfinders in therapeutic medicine. | Eur J Med Chem | 2014 | https://conductscience.org/library/papers/25128670 | PubMed |
| 10 | 30245684 | The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides. | Front Microbiol | 2018 | https://conductscience.org/library/papers/30245684 | PubMed |
| 11 | 30826342 | Tackling antimicrobial resistance 2019-2024 - The UK's five-year national action plan. | J Hosp Infect | 2019 | https://conductscience.org/library/papers/30826342 | PubMed |
| 12 | 23348993 | Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents. | Molecules | 2013 | https://conductscience.org/library/papers/23348993 | PubMed |
| 13 | 27620952 | Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials. | Drug Resist Updat | 2016 | https://conductscience.org/library/papers/27620952 | PubMed |
| 14 | 18274517 | Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. | Nat Protoc | 2008 | https://conductscience.org/library/papers/18274517 | PubMed |
| 15 | 22173342 | What counters antibiotic resistance in nature? | Nat Chem Biol | 2011 | https://conductscience.org/library/papers/22173342 | PubMed |
| 16 | 15655748 | Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? | Clin Infect Dis | 2005 | https://conductscience.org/library/papers/15655748 | PubMed |
| 17 | 34443334 | Quinoxaline Moiety: A Potential Scaffold against Mycobacterium tuberculosis. | Molecules | 2021 | https://conductscience.org/library/papers/34443334 | PubMed |
| 18 | 24465654 | A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi. | PLoS One | 2014 | https://conductscience.org/library/papers/24465654 | PubMed |
| 19 | 37444780 | Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. | Healthcare (Basel) | 2023 | https://conductscience.org/library/papers/37444780 | PubMed |
| 20 | 35065702 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35065702 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40641030 | Crossing Boundaries: A Review of the Diverse Functions of Heterocyclic Compounds in the Management of Cancer and Infectious Diseases. | Curr Drug Targets | 2025 | https://conductscience.org/library/papers/40641030 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39665231
GET https://conductscience.org/api/papers/v1/39665231/references?page=2